kinDOCK: A tool for comparative docking of protein kinase ligands

Nucleic Acids Research

Volumn 34, Issue WEB. SERV. ISS., 2006, Pages

  Martin, Laetitia ^a,b,c   Catherinot, Vincent ^a,b,c   Labesse, Gilles ^a,b,c  

^a CNRS   (France)

^b INSERM   (France)

^c UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

6 (2,6 DICHLOROPHENYL) 2 [3 (HYDROXYMETHYL)ANILINO] 8 METHYLPYRIDO[2,3 D]PYRIMIDIN 7(8H) ONE; 6 (2,6 DICHLOROPHENYL) 8 METHYL 2 (3 METHYLTHIOANILINO) 8H PYRIDO[2,3 D]PYRIMIDIN 7 ONE; ADENINE; ADENOSINE TRIPHOSPHATE; IMATINIB; PP 58; PROTEIN KINASE; PROTEIN KINASE INHIBITOR; STAUROSPORINE; UNCLASSIFIED DRUG; LIGAND;

ACCESS TO INFORMATION; AMINO ACID SUBSTITUTION; ARTICLE; BINDING AFFINITY; BINDING SITE; COMPUTER ANALYSIS; COMPUTER PROGRAM; CONTROLLED STUDY; CRYSTALLIZATION; DRUG STRUCTURE; DRUG TARGETING; GENE LIBRARY; GENE MAPPING; GENE TARGETING; INFORMATION PROCESSING; INTERNET; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DATA BANK; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; CHEMISTRY; COMPUTER INTERFACE; DRUG DESIGN; METABOLISM;

ADENOSINE TRIPHOSPHATE; BINDING SITES; DRUG DESIGN; INTERNET; LIGANDS; PROTEIN CONFORMATION; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; SOFTWARE; USER-COMPUTER INTERFACE;

EID: 33747829589     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkl211     Document Type: Article

References (20)

1. Arora,A. and Scholar,E.M. (2005) Role of tyrosine kinase inhibitors in cancer therapy. J. Pharmacol. Exp. Ther., 315, 971-979.
2. Knighton,D.R., Zheng,J.H., Ten Eyck,L.F., Ashford,V.A., Xuong,N.H., Taylor,S.S. and Sowadski,J.M. (1991) Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science, 253, 407-414.
3. Baker,D. and Sali,A. (2001) Protein structure prediction and structural genomics. Science, 294, 93-96.
4. Hare,B.J., Walters,W.P., Caron,P.R. and Bemis,G.W. (2004) CORES: an automated method for generating three-dimensional models of protein/ ligand complexes. J. Med. Chem., 47, 4731-4740.
5. Cohen-Gonsaud,M., Catherinot,V., Labesse,G. and Douguet,D. (2004) From molecular modelling to drug design. In Rychlewski,K (ed.), Progress in Nucleic Acid Research and Molecular Biology. Springer-Verlag, Vol. 15, pp. 35-71.
6. Shoichet,B.K., McGovern,S.L., Wei,B. and Irwin,J.J. (2002) Lead discovery using molecular docking. Curr. Opin. Chem. Biol., 6, 439-446.
7. Evers,A., Gohlke,H. and Klebe,G. (2003) Ligand-supported homology modelling of protein binding-sites using knowledge-based potentials. J. Mol. Biol., 334, 327-345.
8. Diller,D.J. and Li,R.zz (2003) Kinases, homology models, and high throughput docking. J. Med. Chem., 46, 4638-4647.
9. Noble,M.E., Endicott,J.A. and Johnson,L.N. (2004) Protein kinase inhibitors: insights into drug design from structure. Science, 303, 1800-1805.
10. Deshpande,N., Addess,K.J., Bluhm,W.F., Merino-Ott,J.C., Townsend-Merino,W., Zhang,Q., Knezevich,C., Xie,L., Chen,L., Feng,Z. et al. (2005) The RCSB Protein Data Bank: a redesigned query system and relational database based on the mmCIF schema. Nucleic Acids Res., 33, D233-D237.
11. Hanks,S.K. and Quinn,A.M. (1991) Protein kinase catalytic domain sequence database: identification of conserved features of primary structure and classification of family members. Meth. Enzymol., 200, 38-62.
12. Catherinot,V. and Labesse,G. (2004) ViTO: tool for refinement of protein sequence-structure alignments. Bioinformatics, 20, 3694-3696.
13. Schuttelkopf,A.W. and van Aalten,D.M. (2004) PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta. Crystallogr. D. Biol. Crystallogr., 60, 1355-1363.
14. Wang,R., Liu,L., Lai,L. and Tang,Y. (1998) SCORE: a new empirical method for estimating the binding affinity of a protein-ligand complex. J. Mol. Model, 4, 379-394.
15. Rockey,W.M. and Elcock,A.H. (2005) Rapid computational identification of the targets of protein kinase inhibitors. J. Med. Chem., 48, 4138-4152.
16. Tatton,L., Morley,G.M., Chopra,R. and Khwaja,A. (2003) The Src-selective kinase inhibitor PP1 also inhibits Kit and Bcr-Abl tyrosine kinases. J. Biol. Chem., 278, 4847-4853.
17. Ikuta,M., Kamata,K., Fukasawa,K., Honma,T., Machida,T., Hirai,H., Suzuki-Takahashi,I., Hayama,T. and Nishimura,S. (2001) Crystallographic approach to identification of cyclin-dependent kinase 4 (CDK4)-specific inhibitors by using CDK4 mimic CDK2 protein. J. Biol. Chem., 276, 27548-27554.
18. Rockey,W.M. and Elcock,A.H. (2002) Progress toward virtual screening for drug side effects. Proteins, 48, 664-671.
19. Wissing,J., Godl,K., Brehmer,D., Blencke,S., Weber,M., Habenberger,P., Stein-Gerlach,M., Missio,A., Cotten,M., Muller,S. et al. (2004) Chemical proteomic analysis reveals alternative modes of action for pyrido[2,3-d]pyrimidine kinase inhibitors. Mol. Cell Proteomics, 3, 1181-1193.
20. Cavasotto,C.N. and Abagyan,R.A. (2004) Protein flexibility in ligand docking and virtual screening to protein kinases. J. Mol. Biol., 337, 209-225.